FIELD: chemistry.
SUBSTANCE: present invention refers to the aminopyridin compound of general formula (I) or its salt wherein X1, X2, X3, Z, Y1, Y2 are carbon or nitrogen atom, R, R1, R5, R6 are hydrogen atom, alkyl group, further see formula of the invention, and R7 is hydrogen or halogen atom, nitro or cyano group, -CpH2(p-1)(Ra1)(Ra2)-O-Ra3, -C(=O)-Rd1, 5-or 6-membered saturated heterocycle group, aromatic heterocycle group, -N(Rh1)(Rh2), further see formula of the invention. The invention refers also to the pharmaceutic composition thereof intended for treatment or prevention of allergic diseases, autoimmune diseases caused by malignant tumour, to the Syk inhibitor containing the compound of formula I and to the therapeutic and/or preventive agent.
EFFECT: compounds which not only possess high Syk inhibition activity but are selective Syk inhibitors are obtained and described.
24 cl, 24 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
N, N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REABSORPTION INHIBITORS | 2006 |
|
RU2414454C2 |
COMPOUND, CONTAINING PYRIDINE RING, AND METHOD OF OBTAINING HALOGENATED PICOLINE DERIVATIVE AND TETRAZOLYLOXIME DERIVATIVE | 2011 |
|
RU2512344C1 |
HETEROCYCLIC COMPOUND | 2017 |
|
RU2748693C2 |
NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE | 2010 |
|
RU2567755C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2681211C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
GLUCOKINASE ACTIVATORS | 2007 |
|
RU2457207C2 |
NOVEL PYRAZOLE DERIVATIVES | 2014 |
|
RU2682247C2 |
NEW NICOTINAMIDE DERIVATIVE OR SALT THEREOF | 2011 |
|
RU2560163C2 |
METHODS FOR PREPARING DERIVATIVES OF 1-[2-(BENZIMIDAZOL-1-YL)QUINOLIN-8-YL]PIPERIDIN-4-YLAMINE | 2004 |
|
RU2323214C2 |
Authors
Dates
2009-08-10—Published
2006-02-24—Filed